Related Experiment Video
Updated: Jul 10, 2026
08:30
Glaucoma-inducing Procedure in an In Vivo Rat Model and Whole-mount Retina Preparation
Published on: March 12, 2016
Beta blocker eye drops related airway obstruction
JPMA. the Journal of the Pakistan Medical Association
|July 27, 2001
Summary
Ophthalmologists demonstrated greater awareness of beta blocker eye drops worsening breathlessness in obstructive airway disease patients compared to chest physicians. Patient awareness of these risks remains low, necessitating improved education.
Area of Science:
- Ophthalmology
- Pulmonology
- Pharmacology
Background:
- Beta blocker eye drops, like timolol, are commonly prescribed for glaucoma.
- These medications can exacerbate respiratory conditions such as obstructive airway disease.
- Awareness of this potential side effect among healthcare providers and patients is crucial.
Purpose of the Study:
- To evaluate the awareness levels of chest physicians, ophthalmologists, and patients regarding the use of beta blocker eye drops.
- To specifically assess the understanding of the risk of breathlessness aggravation in predisposed individuals.
Main Methods:
- A cross-sectional survey was conducted.
- Participants included 20 chest physicians, 20 ophthalmologists, and 200 patients with obstructive airway disease.
- Data was collected from two hospitals and a welfare center in Karachi.
Main Results:
- Ophthalmologists exhibited significantly higher awareness (p = 0.004) than chest physicians concerning beta blocker eye drop use in obstructive airway disease patients.
- Patient awareness regarding the respiratory side effects of these eye drops was found to be low.
Conclusions:
- There is a clear need to enhance medical professionals' knowledge on the potential respiratory risks associated with beta blocker eye drops.
- Public education campaigns are essential to inform patients about the side effects of these medications, particularly those with obstructive airway disease.
Related Concept Videos
01:11Direct-Acting Cholinergic Agonists: Therapeutic Uses
Direct-acting cholinergic agonists have many therapeutic uses in various medical fields. Choline esters, including acetylcholine, have limited clinical utility due to their non-selectivity and short duration of action. Still, acetylcholine and carbachol are applied topically during ophthalmologic surgery to induce miosis. Pilocarpine, a muscarinic and ganglionic stimulator, effectively treats open-angle glaucoma and alleviates xerostomia and dry mouth caused by radiotherapy or Sjögren syndrome.
01:27Adrenergic Antagonists: Pharmacological Actions of β-Receptor Blockers
β-receptor blockers significantly impact the cardiovascular system by counteracting catecholamine-induced sympathetic responses. These medications decrease heart rate, contractility, and cardiac output, potentially leading to cardiac depression, life-threatening bradycardia, and death. Therapeutically, β-blockers function as mild antihypertensives and are utilized in treating angina pectoris and cardiac arrhythmias. However, nonselective β-blockers inhibit β2-receptors in bronchial smooth...
01:27Open Angle Glaucoma: Treatment
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
01:28Angle Closure Glaucoma: Treatment
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
01:28Antihypertensive Drugs: Types of β-Blockers
β receptors are classified into three subclasses: β1, β2, and β3. β1 receptors are primarily located in the heart and kidneys. When they get activated, they increase heart rate, contractility, and renin release. This process enhances blood pressure and aids in stress management. In contrast, β2 receptors are situated mainly in the lungs, blood vessels, and skeletal muscles. Upon activation, they trigger smooth muscle relaxation, causing bronchodilation and vasodilation. This widens airways and...
01:25Antiasthma Drugs: β2-Adrenoceptor Agonists
Bronchodilators are critical in managing asthma, a chronic respiratory condition characterized by airway constriction due to inflammation and hyper-reactivity. Specifically, bronchodilators ease this constriction by relaxing the bronchial muscles, facilitating easier breathing.
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce relaxation in these...
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce relaxation in these...